Mucormycosis Clinical Trials

9 recruitingLast updated: July 25, 2026

There are 9 actively recruiting mucormycosis clinical trials across 6 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Bethesda, Maryland, United States, Chandigarh, Chandigarh, India, Dalian, China. Updated daily from ClinicalTrials.gov.


Mucormycosis Trials at a Glance

9 actively recruiting trials for mucormycosis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Bethesda, Chandigarh, and Dalian. Lead sponsors running mucormycosis studies include Latakia University, M.D. Anderson Cancer Center, and Institute of Hematology & Blood Diseases Hospital, China.

Browse mucormycosis trials by phase

Treatments under study

About Mucormycosis Clinical Trials

Looking for clinical trials for Mucormycosis? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mucormycosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mucormycosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1

Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

AspergillosMucormyeDimorphic+3 more
National Institutes of Health Clinical Center (CC)100 enrolled1 locationNCT07704333
Recruiting

Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project

Mucormycosis
M.D. Anderson Cancer Center300 enrolled1 locationNCT06878144
Recruiting
Not Applicable

Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction.

Facial asymmetryOral Squamous Cell CarcinomaMucormycosis+3 more
Latakia University30 enrolled1 locationNCT07654647
Recruiting

Biomarkers for Invasive Mucormycosis

Mucorales InfectionMucormycosis
University Hospital, Lille100 enrolled1 locationNCT05406037
Recruiting

Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value

Pulmonary Mucormycosis
University Hospital, Strasbourg, France80 enrolled1 locationNCT07339800
Recruiting

Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

Mucormycosis in Hematologic Malignancies
Institute of Hematology & Blood Diseases Hospital, China60 enrolled9 locationsNCT07185503
Recruiting

Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

AspergillosisMucormycosis
Pfizer600 enrolled1 locationNCT04744454
Recruiting
Not Applicable

Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children

MucormycosisAspergillosis Invasive
Shanghai Children's Medical Center200 enrolled1 locationNCT06440915
Recruiting
Phase 2

Amphotericin Versus Posaconazole for Pulmonary Mucormycosis

Mucormycosis; Pulmonary (Etiology)
Post Graduate Institute of Medical Education and Research, Chandigarh50 enrolled1 locationNCT05468372